We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Pay-for-delay deals “hurt consumers twice,” by delaying the introduction of cheaper generics and by stifling competition among multiple generics companies, the bill’s sponsor said. Read More
The device works with the MagVenture, which has been OK’d by the FDA for the treatment of major depressive disorder in patients who have not seen satisfactory improvement from antidepressant meds. Read More
BSI said that when it initiated its contingency plan in August 2016, it “could not have foreseen the lack of political progress” toward a Brexit resolution. Read More